Russell Investments Group’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.33M | Buy |
90,725
+11,805
| +15% | +$495K | ﹤0.01% | 1466 |
|
|
2026
Q1 | $2.54M | Buy |
78,920
+5,946
| +8% | +$220K | ﹤0.01% | 1738 |
|
|
2025
Q4 | $3.07M | Buy |
72,974
+61
| +0.1% | +$2.46K | ﹤0.01% | 1623 |
|
|
2025
Q3 | $2.5M | Buy |
72,913
+24,127
| +49% | +$692K | ﹤0.01% | 1745 |
|
|
2025
Q2 | $1.32M | Buy |
48,786
+11,889
| +32% | +$344K | ﹤0.01% | 1927 |
|
|
2025
Q1 | $1.09M | Sell |
36,897
-28,644
| -44% | -$1.09M | ﹤0.01% | 1994 |
|
|
2024
Q4 | $2.6M | Buy |
65,541
+45,876
| +233% | +$1.74M | ﹤0.01% | 1533 |
|
|
2024
Q3 | $669K | Buy |
19,665
+8,652
| +79% | +$243K | ﹤0.01% | 2179 |
|
|
2024
Q2 | $239K | Sell |
11,013
-14,063
| -56% | -$296K | ﹤0.01% | 2433 |
|
|
2024
Q1 | $556K | Sell |
25,076
-59,732
| -70% | -$1.46M | ﹤0.01% | 2171 |
|
|
2023
Q4 | $2.33M | Buy |
84,808
+42,866
| +102% | +$1.03M | ﹤0.01% | 1541 |
|
|
2023
Q3 | $937K | Buy |
41,942
+41,121
| +5,009% | +$1.06M | ﹤0.01% | 1967 |
|
|
2023
Q2 | $20.9K | Sell |
821
-386
| -32% | -$9.36K | ﹤0.01% | 2836 |
|
|
2023
Q1 | $26.9K | Buy |
+1,207
| New | +$29.2K | ﹤0.01% | 2784 |
|
|
2022
Q2 | – | Sell |
-14,135
| Closed | -$389K | – | 2968 |
|
|
2022
Q1 | $389K | Sell |
14,135
-58,978
| -81% | -$1.69M | ﹤0.01% | 2303 |
|
|
2021
Q4 | $3.01M | Buy |
73,113
+29,360
| +67% | +$1.3M | ﹤0.01% | 1569 |
|
|
2021
Q3 | $2.03M | Buy |
43,753
+13,165
| +43% | +$574K | ﹤0.01% | 1824 |
|
|
2021
Q2 | $1.22M | Sell |
30,588
-68,556
| -69% | -$2.93M | ﹤0.01% | 2212 |
|
|
2021
Q1 | $5.33M | Sell |
99,144
-8,711
| -8% | -$502K | 0.01% | 1342 |
|
|
2020
Q4 | $5.28M | Sell |
107,855
-72,392
| -40% | -$3.35M | 0.01% | 1214 |
|
|
2020
Q3 | $5.86M | Buy |
180,247
+48,954
| +37% | +$1.56M | 0.01% | 1045 |
|
|
2020
Q2 | $3.4M | Buy |
131,293
+146
| +0.1% | +$3.64K | 0.01% | 1323 |
|
|
2020
Q1 | $3.19M | Sell |
131,147
-100,212
| -43% | -$2.52M | 0.01% | 1215 |
|
|
2019
Q4 | $6.46M | Buy |
231,359
+93,153
| +67% | +$2.41M | 0.01% | 1070 |
|
|
2019
Q3 | $3.32M | Sell |
138,206
-106,887
| -44% | -$2.84M | 0.01% | 1403 |
|
|
2019
Q2 | $6.97M | Buy |
245,093
+47,367
| +24% | +$1.18M | 0.01% | 1067 |
|
|
2019
Q1 | $4.95M | Buy |
197,726
+31,958
| +19% | +$610K | 0.01% | 1234 |
|
|
2018
Q4 | $2.08M | Sell |
165,768
-55,270
| -25% | -$654K | ﹤0.01% | 1590 |
|
|
2018
Q3 | $2.11M | Buy |
+221,038
| New | +$2.44M | ﹤0.01% | 1729 |
|
|
2017
Q4 | – | Sell |
-18,829
| Closed | -$165K | – | 3012 |
|
|
2017
Q3 | $165K | Buy |
18,829
+5,176
| +38% | +$42.1K | ﹤0.01% | 2703 |
|
|
2017
Q2 | $114K | Sell |
13,653
-2,348
| -15% | -$19.2K | ﹤0.01% | 2787 |
|
|
2017
Q1 | $147K | Buy |
+16,001
| New | +$131K | ﹤0.01% | 2765 |
|
Other funds holding VCYT
AIM
JAM
AAMU
Russell Investments Group's VCYT Position: Q2 2026 in Review
Russell Investments Group increased its Veracyte (VCYT) stake by 15% in Q2 2026, buying an estimated $495K and bringing the position to 90,725 shares worth $5.33M. The position accounts for ﹤0.01% of the portfolio, ranked #1466.
Russell Investments Group first reported a position in VCYT in Q1 2017 and has held it in 32 quarters since. The position peaked at $6.97M in Q2 2019. 160 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- Russell Investments Group held 90,725 shares of Veracyte worth $5.33M as of Q2 2026.
- Russell Investments Group bought 11,805 Veracyte shares in Q2 2026, an estimated $495K.
- Veracyte made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #1466 holding.
- Russell Investments Group first reported a position in Veracyte in Q1 2017 and has held it in 32 quarters since.
- Russell Investments Group's Veracyte position peaked at $6.97M in Q2 2019.
- 160 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.